Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
+ - Regulatory Standing: Classified as an experimental small molecule
KLOW Peptide Dosage The standard KLOW-80 vial contains four peptides in a fixed mass ratio: 50 mg GHK-Cu and 10 mg each of BPC-157, TB-4, and KPV
References PubMed Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds Current Pharmaceutical Design (PubMed) Stable gastric pentadecapeptide BPC-157: novel therapy in gastrointestinal tract PMC Utilizing developmentally essential secreted peptides such as Thymosin Beta-4 for regenerative therapies Annals of the New York Academy of Sciences (PubMed) Thymosin beta 4 and wound healing: new ideas PMC Emerging use of BPC-157 in orthopaedic sports medicine: a systematic review Johns Hopkins Arthritis Center How to give a subcutaneous injection PMC Subcutaneous drug delivery review: pharmacologic considerations ASIPP / Alternative Therapies in Health and Medicine Intra-articular injection of BPC-157 for multiple types of knee pain A4M Thymosin Beta-4 professional monograph PubMed Detection of thymosin beta-4 and related peptides in sport drug testing Journal of Physiology and Pharmacology (PubMed) BPC-157 activity at very low doses without toxicity in animal studies Expert Opinion on Biological Therapy (PubMed) Thymosin beta-4 and its role in wound healing CDC Vaccine administration: subcutaneous route (angle/site
& Niesen, W
Med Sci Monit Basic Res
Weight Regulation 3
